Cannformatics

Excited to welcome Congressman Edward Feighan to the Cannformatics team. Mr. Feighan's experience as a policy maker and as Executive Chairman of Vitality Biopharma makes him uniquely qualified to advice the company as we work to discover and apply evidence-based knowledge in the use of medical cannabis. https://www.prnewswire.com//former-us-congressman-edward-f

The Cannformatics family keeps growing.

Great to see our ASD Pilot Study get positive media in the UK. More news to come from this important study. Thank you to our sponsors Canniatric and WPA4A, Inc. for their ongoing support. https://cannabishealthnews.co.uk//cannabis-could-be-used/

Cannformatics hit an important milestone today announcing that we received IRB approval for our pilot study focused on children with autism. Now the real work begins as we take the first steps toward personalizing medical cannabis treatments. https://www.prnewswire.com//cannformatics-receives-approva

Watch how we’re using metabolomics and AI to develop personalized medical cannabis recommendations. https://youtu.be/JQtNBqTZx7A